Literature DB >> 2199126

Influence of exercise on the pharmacokinetics of drugs.

M A van Baak1.   

Abstract

Since many patients with a wide variety of diseases are nowadays stimulated to adopt a physically active lifestyle, the question of the influence of exercise on the pharmacokinetics of drugs has become more and more relevant. Because exercise influences a large number of physiological factors that also determine the pharmacokinetics of drugs, including haemodynamics, metabolism, pH, temperature and gastrointestinal function, it can be expected to have an effect on the pharmacokinetic parameters (absorption, distribution, elimination) of certain agents. However, only a very limited number of studies has been directed towards this issue, and only a very few drugs have been studied. Nevertheless, it is clear that exercise does influence the pharmacokinetics of certain drugs, although the magnitude and direction of the effects vary. This is not surprising in view of the widely differing physicochemical properties of drugs, the many possible--often opposing--effects of exercise on the parameters affecting drug pharmacokinetics and the different types of exercise performed. The chance of a clinically relevant effect of exercise on the pharmacokinetics of a particular drug is largest in those with a steep dose-response curve, a narrow therapeutic range, a need for continuity of therapeutic effectiveness and a relatively short half-life, in combination with intensive exercise of long duration. If untoward drug effects occur during or after exercise, a change in the pharmacokinetics of the drug related to the exercise should be seriously considered as a possible cause.

Entities:  

Mesh:

Year:  1990        PMID: 2199126     DOI: 10.2165/00003088-199019010-00003

Source DB:  PubMed          Journal:  Clin Pharmacokinet        ISSN: 0312-5963            Impact factor:   6.447


  50 in total

1.  The effects of moderate sustained exercise on the pharmacokinetics of nitroglycerine.

Authors:  S Weber; D de Lauture; E Rey; T Darragon; J P Severins; A Ditisheim; G Olive; M Degeorges
Journal:  Br J Clin Pharmacol       Date:  1987-01       Impact factor: 4.335

2.  Renal function during prolonged exercise.

Authors:  J Castenfors
Journal:  Ann N Y Acad Sci       Date:  1977       Impact factor: 5.691

Review 3.  Human cardiovascular adjustments to exercise and thermal stress.

Authors:  L B Rowell
Journal:  Physiol Rev       Date:  1974-01       Impact factor: 37.312

4.  Dissociation of insulin absorption and blood flow during massage of a subcutaneous injection site.

Authors:  B Linde
Journal:  Diabetes Care       Date:  1986 Nov-Dec       Impact factor: 19.112

5.  Physical exercise and binding of digoxin to skeletal muscle--effect of muscle activation frequency.

Authors:  T Joreteg; T Jogestrand
Journal:  Eur J Clin Pharmacol       Date:  1984       Impact factor: 2.953

6.  Drugs--some basic concepts.

Authors:  G D Sweeney
Journal:  Med Sci Sports Exerc       Date:  1981       Impact factor: 5.411

Review 7.  Effect of acute and chronic exercise on hepatic drug metabolism.

Authors:  M Døssing
Journal:  Clin Pharmacokinet       Date:  1985 Sep-Oct       Impact factor: 6.447

8.  Effects of physical exercise on insulin absorption in insulin-dependent diabetics. A comparison between human and porcine insulin.

Authors:  E Fernqvist; B Linde; J Ostman; R Gunnarsson
Journal:  Clin Physiol       Date:  1986-12

9.  Effect of exercise on thyroid parameters and on metabolic clearance rate of antipyrine in man.

Authors:  P Theilade; J M Hansen; L Skovsted; J P Kampmann
Journal:  Acta Endocrinol (Copenh)       Date:  1979-10

10.  The effects of exercise and adrenaline infusion upon the blood levels of propranolol and antipyrine in the horse.

Authors:  G Powis; D H Snow
Journal:  J Pharmacol Exp Ther       Date:  1978-06       Impact factor: 4.030

View more
  9 in total

1.  Exercise and the pharmacokinetics of propranolol, verapamil and atenolol.

Authors:  M A van Baak; J M Mooij; P M Schiffers
Journal:  Eur J Clin Pharmacol       Date:  1992       Impact factor: 2.953

Review 2.  The influence of cardiovascular physiology on dose/pharmacokinetic and pharmacokinetic/pharmacodynamic relationships.

Authors:  Pietro Fagiolino; Rosa Eiraldi; Marta Vázquez
Journal:  Clin Pharmacokinet       Date:  2006       Impact factor: 6.447

3.  Effects of a sauna on the pharmacokinetics and pharmacodynamics of midazolam and ephedrine in healthy young women.

Authors:  J Vanakoski; C Strömberg; T Seppälä
Journal:  Eur J Clin Pharmacol       Date:  1993       Impact factor: 2.953

Review 4.  Pharmacokinetic studies in healthy volunteers in the context of in vitro/in vivo correlations.

Authors:  B Oosterhuis; J H Jonkman
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1993 Jan-Mar       Impact factor: 2.441

5.  Human pharmacology of a performance-enhancing dietary supplement under resting and exercise conditions.

Authors:  Christine A Haller; Minjing Duan; Peyton Jacob; Neal Benowitz
Journal:  Br J Clin Pharmacol       Date:  2008-03-13       Impact factor: 4.335

Review 6.  Potential interactions between exercise and drug therapy.

Authors:  Thomas L Lenz; Nancy J Lenz; Michele A Faulkner
Journal:  Sports Med       Date:  2004       Impact factor: 11.136

7.  Acute physical exercise is safe in patients with primary antiphospholipid syndrome with exclusive venous thrombosis and under oral anticoagulation with warfarin.

Authors:  Carolina Borges Garcia; Luciana Parente Costa Seguro; Luiz Augusto Perandini; Ana Lúcia de Sá Pinto; Fernanda Rodrigues Lima; Carlos Eduardo Negrão; Eloisa Bonfa; Eduardo Ferreira Borba
Journal:  Rheumatol Int       Date:  2014-05-14       Impact factor: 2.631

8.  Activation of 5-HT1C-receptors suppresses excessive wheel running induced by semi-starvation in the rat.

Authors:  T Wilckens; U Schweiger; K M Pirke
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

9.  Impact of regular physical activity on weekly warfarin dose requirement.

Authors:  Étienne Rouleau-Mailloux; Payman Shahabi; Stéphanie Dumas; Yassamin Feroz Zada; Sylvie Provost; Jason Hu; Jacqueline Nguyen; Nawal Bouchama; Ian Mongrain; Mario Talajic; Jean-Claude Tardif; Sylvie Perreault; Marie-Pierre Dubé
Journal:  J Thromb Thrombolysis       Date:  2016-02       Impact factor: 2.300

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.